Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future

Lung cancer is the most frequent cancer with an aggressive clinical course and high mortality rates. Most cases are diagnosed at advanced stages when treatment options are limited and the efficacy of chemotherapy is poor. The disease has a complex and heterogeneous background with non-small-cell lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Uras, Iris Z., Moll, Herwig P., Casanova, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352653/
https://www.ncbi.nlm.nih.gov/pubmed/32560574
http://dx.doi.org/10.3390/ijms21124325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7352653/
https://www.ncbi.nlm.nih.gov/pubmed/32560574
http://dx.doi.org/10.3390/ijms21124325

Ejemplares similares